Prenetics Global, a Nasdaq-listed health sciences company, has announced a successful funding round of $48 million to bolster its bitcoin holdings and support the expansion of its supplement brand, IM8. The equity offering, which was oversubscribed, underscores notable interest from a variety of crypto-focused firms and high-profile investors. With this capital infusion, Prenetics aims to fortify its treasury strategy and set ambitious global business goals.
$48 Million Raised to Support Bitcoin and IM8 Growth
On October 28, 2025, Prenetics disclosed that it had secured $48 million in gross proceeds from an equity offering that attracted significant attention within the cryptocurrency ecosystem. Noteworthy investors included well-known names such as Kraken, Exodus, GPTX, and American Ventures, along with tennis star Aryna Sabalenka and Hong Kong businessman Adrian Cheng, both of whom increased their stakes in the company. Prenetics currently counts football icon David Beckham among its existing shareholders.
According to their announcement, the arrangement could generate up to $216 million in total proceeds if all warrants are exercised, signaling strong investor confidence in Prenetics’ dual strategy. CEO Danny Yeung highlighted that the fresh funds would be utilized to accelerate IM8’s global expansion while further advancing the company’s disciplined approach to accumulating bitcoin as part of its treasury initiatives.
Prenetics Expands Bitcoin Treasury Strategy
Initiated in August 2025, Prenetics’ bitcoin treasury initiative aims to acquire one bitcoin daily. As of October 27, the company has amassed approximately 275 BTC, valued at around $31 million. This latest funding round is expected to enhance the company’s liquidity to roughly $131 million, allowing them to not only maintain their trajectory of crypto asset accumulation but also expand their operational reach.
Prenetics has set its sights on long-term goals, aspiring to achieve $1 billion in both annual revenue and bitcoin holdings within five years, a clear indication of their aggressive growth strategy in the digital asset space.
IM8 Supplement Brand Shows Fast Revenue Growth
In conjunction with its cryptocurrency strategy, Prenetics is making significant strides in advancing IM8, its supplement brand co-founded with David Beckham. Remarkably, IM8 has achieved $100 million in recurring revenue within just 11 months of launch and is forecasting revenue between $160 million and $200 million in 2026. This rapid growth reflects the brand’s rising popularity and is set to be further bolstered by new investments as part of Prenetics’ overall expansion strategy.
The capital raised will be directed toward increasing IM8’s global presence, with plans to expand its product offerings significantly over the next year.
Stock Reaction and Outlook
Following the funding announcement, Prenetics’ stock experienced a decline, falling 21.96% to a closing price of $13.08 on Monday. However, it bounced back with a 4.51% increase in after-hours trading. Despite the recent downturn, the company has seen a remarkable 161% rise in its stock over the past six months, indicating a potentially positive longer-term outlook.
This equity raise occurs in a climate of market volatility, yet investor enthusiasm remains high for Prenetics’ innovative dual focus on health products and digital assets. With a solid backing and a well-defined growth trajectory, the company is poised to make significant advancements in both the cryptocurrency market and its health-oriented business segments.
